Lenire Tinnitus Treatment Device Available in Canada
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
The free, one-day online event will connect healthcare professionals and patients with tinnitus experts on research and management strategies.
Neuromod Devices has achieved both Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification, enabling expanded global availability of its Lenire tinnitus treatment device in Europe, Canada, Australia, and beyond.
While there is no cure for tinnitus, don’t tell patients there is nothing they can do. Many treatment options exist to ease the burden.
Tinnitus is a common condition that can be difficult for hearing care professionals to treat and manage. MedRx makes it easier with a new test available in MedRx Studio software.
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.